8-K - Phio Pharmaceuticals Corp. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On January 20, 2026, the Company issued a press release announcing key tumor response data from all cohorts in their intratumoral PH-762 dose es

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by the Company on January 20, 2026. 104 Cover Page Interacti

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1